Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Biosafety Virtual Library Resources
(VLR)
last updated: 28 Apr 2011
Public GM Innovations, Safety Regulation, and ….. Results?
EN
- Inter-governmental organization (IGO)
2033 K Street, NW
Washington,
DC20006-1002, United States of America
Phone: +1 202 862 5600,
Fax: +1 202 467 4439,
Email: ifpri@cgiar.org,
Website: http://www.ifpri.org/ ,
International Food Policy Research Institute (IFPRI), Washington DC, USA
EN
2005-03
EN
Abstract
Disputes continue to flare over genetically modified (GM) crops, and their potential to enhance livelihoods in agricultural communities in developing nations. Benefits have been documented for a few GM crops, especially insect-resistant cotton. However, official permission to plant GM seeds on a commercial scale has not been granted in most countries, including a wide range of crops engineered by public research institutes in developing countries. This paper will examine progress in GM crop research from poorer nations, its regulatory status and direction, and whether or not results from this work can reach farmers. It does so by examining public GM research among 16 developing countries as demonstrations of innovation, then looking at the remaining steps they face particularly with regard to biosafety regulation. Recommendations addressing the study’s implications are presented in the conclusion.
Table of Contents:
INTRODUCTION
SCOPE
CAN PUBLIC GM RESEARCH PRODUCE CROPS WITH QUALITY-OF-LIFE BENEFITS?
EVOLVING REGIONAL CAPACITIES
GM CROPS AND REGULATORY DEVELOPMENT
BIOSAFETY REGULATIONS AND RISK ASSESSMENT: EVOLVING NATIONAL AND INTERNATIONAL INSTRUMENTS
CONCLUDING REMARKS
EN
Disputes continue to flare over genetically modified (GM) crops, and their potential to enhance livelihoods in agricultural communities in developing nations. Benefits have been documented for a few GM crops, especially insect-resistant cotton. However, official permission to plant GM seeds on a commercial scale has not been granted in most countries, including a wide range of crops engineered by public research institutes in developing countries. This paper will examine progress in GM crop research from poorer nations, its regulatory status and direction, and whether or not results from this work can reach farmers. It does so by examining public GM research among 16 developing countries as demonstrations of innovation, then looking at the remaining steps they face particularly with regard to biosafety regulation. Recommendations addressing the study’s implications are presented in the conclusion.
Table of Contents:
INTRODUCTION
SCOPE
CAN PUBLIC GM RESEARCH PRODUCE CROPS WITH QUALITY-OF-LIFE BENEFITS?
EVOLVING REGIONAL CAPACITIES
GM CROPS AND REGULATORY DEVELOPMENT
BIOSAFETY REGULATIONS AND RISK ASSESSMENT: EVOLVING NATIONAL AND INTERNATIONAL INSTRUMENTS
CONCLUDING REMARKS
- GBF-T17. Strengthen biosafety and distribute benefits of biotechnology
No
No
No
Identifier (ISBN, ISSN, etc.)
Format
18 page PDF file
